# LIPS-B: Lung Injury Prevention Study With Budesonide and Beta

> **NCT01783821** · PHASE2 · COMPLETED · sponsor: **Mayo Clinic** · enrollment: 61 (actual)

## Conditions studied

- Acute Respiratory Distress Syndrome (ARDS)

## Interventions

- **DRUG:** Budesonide
- **DRUG:** Placebo
- **DRUG:** Formoterol

## Key facts

- **NCT ID:** NCT01783821
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-07
- **Primary completion:** 2015-07
- **Final completion:** 2015-12
- **Target enrollment:** 61 (ACTUAL)
- **Last updated:** 2016-09-05

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01783821

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01783821, "LIPS-B: Lung Injury Prevention Study With Budesonide and Beta". Retrieved via MORVS 2026-10-23 from https://api.morvs.ai/clinical/NCT01783821. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*